Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.


Player Avatar pennysplants (99.53) Submitted: 11/25/2012 2:04:22 PM : Outperform Start Price: $4.11 LXRX Score: -58.03

BUSTED ! "potential" already baked into current share price which is much below my entry point. Cut losses and move on. Cleaning up after 2 year hiatus from CAPS.

Featured Broker Partners